Acical-C Effervescent Tablet 1000 mg+327 mg+500 mg

Acical-C Effervescent Tablet is a calcium and vitamin C supplement manufactured by ACI Limited. Combining Calcium Lactate Gluconate (1000 mg), Calcium Carbonate (327 mg), and Vitamin C (500 mg), this effervescent tablet addresses multiple deficiencies and supports bone health, immunity, and recovery processes.

Priced at ৳15.00 per tablet (strip of 10: ৳150.00), it’s prescribed for calcium/vitamin C deficiencies, osteoporosis, pregnancy/lactation needs, and infection management. The formula enhances calcium absorption while providing antioxidant benefits. Dissolve one tablet daily in water after meals (½ tablet for children aged 3-7).

Key indications include PMS, menopausal issues, growth spurts, and adjunct treatment for colds/flu. As part of calcium-vitamin C combinations, it interacts cautiously with digoxin, tetracyclines, and diuretics but synergizes with iron supplements and vitamin D.

Reported side effects are mild – bloating or diarrhea. Safe during pregnancy/lactation, but prolonged use may increase kidney stone risk in predisposed patients. Store below 30°C, protected from moisture.

3-7 years: Half tablet daily dissolved in water. 7+ years & adults: 1 tablet daily. Renal impairment patients may need dose reduction. Administer immediately after dissolution. Treatment duration varies from 3-6 months based on clinical response.

In rare cases, mild gastrointestinal disturbances (bloating, diarrhea) can occur. In predisposed patients, prolonged treatment with high doses may promote the formation of calculi in the urinary tract.

Pregnancy Category A. Calcium excreted minimally in breast milk. Monitor serum calcium levels during pregnancy. Safe for lactating mothers at recommended doses.

Monitor urinary calcium in renal patients. Avoid high vitamin D intake. Diabetics should account for tablet’s sugar content. Citrate component may increase aluminum absorption in renal impairment.

Elderly patients prone to GI side effects. Dose adjustment required in renal impairment. Pediatric dosing based on age. No specific hepatic dose adjustment.

Acute overdosage has not been reported. It would be expected to cause gastrointestinal disturbances but not to result in hypercalcemia, except in patients treated with a very high dosage of vitamin-D and derivatives.